Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Gilead Pharmasset Llc patents

Recent patent applications related to Gilead Pharmasset Llc. Gilead Pharmasset Llc is listed as an Agent/Assignee. Note: Gilead Pharmasset Llc may have other listings under different names/spellings. We're not affiliated with Gilead Pharmasset Llc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "G" | Gilead Pharmasset Llc-related inventors




Date Gilead Pharmasset Llc patents (updated weekly) - BOOKMARK this page
11/16/17 new patent  Solid forms of an antiviral compound
09/07/17Preparation of 2'-fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
08/31/17Solid forms of an antiviral compound
07/20/17Combination formulation of two antiviral compounds
07/06/17Methods for treating hcv
06/29/17Process for the preparation of a fluorolaction derivative
05/25/17Antiviral compounds
04/06/17Combination formulation of two antiviral compounds
02/02/17Antiviral compounds
12/08/16Nucleoside phosphoramidates
12/08/16Methods for treating hcv
11/24/16Synthesis of antiviral compound
09/29/162',4'-substituted nucleosides as antiviral agents
05/05/16Combination formulation of two antiviral compounds
04/28/16Antiviral compounds
03/24/16Antiviral compounds
01/28/16Preparation of 2'-fluoro-2'-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
12/17/15Processes for preparing antiviral compounds
12/17/15Solid forms of an antiviral compound
12/10/15Antiviral compounds
12/03/15Solid forms of an antiviral compound
10/22/15Antiviral compounds
08/20/15Nucleoside phosphoramidate prodrugs
08/20/15Synthesis of antiviral compound
06/25/15Solid forms of an antiviral compound
06/04/15Compositions and methods for treating hepatitis c virus
06/04/15Methods of treating hepatitis c virus infection in subjects with cirrhosis
05/21/15Antiviral compounds
05/21/15Solid forms of an antiviral compound
03/05/15Solid dispersion formulation of an antiviral compound
03/05/15Combination formulation of two antiviral compounds
01/15/15Compounds
12/04/14Methods of preventing and treating recurrence of a hepatitis c virus infection in a subject after the subject has received a liver transplant
10/23/14Nucleoside phosphoramidate prodrugs
09/25/14Nucleoside phosphoramidate prodrugs
09/04/14Antiviral compounds
08/21/142',4'-substituted nucleosides as antiviral agents
07/03/14Nucleoside phosphoramidate prodrugs
05/01/14Nucleoside phosphoramidates
02/13/14Nucleoside phosphoramidate prodrugs
09/19/13Methods for treating hcv
08/29/13Nucleoside phosphoramidates
06/27/13Nucleoside phosphoramidates
06/27/13Nucleoside phosphoramidates
05/30/13Compositions and methods for treating hepatitis c virus
05/30/13Nucleoside phosphoramidates
05/02/13Methods and compositions for treating hepatitis c virus
01/31/13Nucleoside phosphoramidate prodrugs
12/13/12Synthesis of purine nucleosides
10/11/12Nucleoside cyclicphosphates
09/27/12Modified fluorinated nucleoside analogues







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Gilead Pharmasset Llc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gilead Pharmasset Llc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';